483
Biolink Life Sciences Carolinas Inc.FDA 483 - Biolink Life Sciences Carolinas Inc. - July 21, 2025
Record Details
Biolink Life Sciences Carolinas Inc. in Cary, NC, a laboratory, was cited for significant deficiencies during an FDA inspection. Observations included failures to follow Quality Unit procedures, maintain complete laboratory records due to inaccessible data from a decommissioned server, and adequately qualify critical laboratory equipment. These issues collectively compromise data integrity and the reliability of analytical results for drug substance batch release.
Open in Dashboard
ID · 94ac826e-dad8-4aed-9499-3e4fe51f3831